Clinical Trial Update: Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated immune responses and antibody persistence in UK infants receiving multiple vaccines, including boosters in the second year of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infection
• Pneumococcal Infection

Snippet

Sponsor: Public Health England | Conditions: Meningococcal Infections, Pneumococcal Infections | Phase 4 | Status: COMPLETED